These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1421 related articles for article (PubMed ID: 9065401)

  • 1. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.
    Korinek V; Barker N; Morin PJ; van Wichen D; de Weger R; Kinzler KW; Vogelstein B; Clevers H
    Science; 1997 Mar; 275(5307):1784-7. PubMed ID: 9065401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.
    Morin PJ; Sparks AB; Korinek V; Barker N; Clevers H; Vogelstein B; Kinzler KW
    Science; 1997 Mar; 275(5307):1787-90. PubMed ID: 9065402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
    Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
    Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.
    Wakita K; Tetsu O; McCormick F
    Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Yin-Yang of TCF/beta-catenin signaling.
    Barker N; Morin PJ; Clevers H
    Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
    Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
    Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway.
    Wielenga VJ; Smits R; Korinek V; Smit L; Kielman M; Fodde R; Clevers H; Pals ST
    Am J Pathol; 1999 Feb; 154(2):515-23. PubMed ID: 10027409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
    Tetsu O; McCormick F
    Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of beta-catenin TCF signaling is linked to colonic epithelial cell differentiation.
    Mariadason JM; Bordonaro M; Aslam F; Shi L; Kuraguchi M; Velcich A; Augenlicht LH
    Cancer Res; 2001 Apr; 61(8):3465-71. PubMed ID: 11309309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
    Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
    Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-catenin as oncogene: the smoking gun.
    Peifer M
    Science; 1997 Mar; 275(5307):1752-3. PubMed ID: 9122680
    [No Abstract]   [Full Text] [Related]  

  • 12. Gut-enriched Krüppel-like factor regulates colonic cell growth through APC/beta-catenin pathway.
    Stone CD; Chen ZY; Tseng CC
    FEBS Lett; 2002 Oct; 530(1-3):147-52. PubMed ID: 12387883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential formation of beta-catenin/lymphoid enhancer factor-1 DNA binding complex induced by nitric oxide in mouse colonic epithelial cells differing in adenomatous polyposis coli (Apc) genotype.
    Mei JM; Hord NG; Winterstein DF; Donald SP; Phang JM
    Cancer Res; 2000 Jul; 60(13):3379-83. PubMed ID: 10910042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors.
    Pannequin J; Delaunay N; Buchert M; Surrel F; Bourgaux JF; Ryan J; Boireau S; Coelho J; Pélegrin A; Singh P; Shulkes A; Yim M; Baldwin GS; Pignodel C; Lambeau G; Jay P; Joubert D; Hollande F
    Gastroenterology; 2007 Nov; 133(5):1554-68. PubMed ID: 17920061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
    Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
    Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis.
    Yamada T; Takaoka AS; Naishiro Y; Hayashi R; Maruyama K; Maesawa C; Ochiai A; Hirohashi S
    Cancer Res; 2000 Sep; 60(17):4761-6. PubMed ID: 10987283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of c-MYC as a target of the APC pathway.
    He TC; Sparks AB; Rago C; Hermeking H; Zawel L; da Costa LT; Morin PJ; Vogelstein B; Kinzler KW
    Science; 1998 Sep; 281(5382):1509-12. PubMed ID: 9727977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
    Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
    Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Drosophila homolog of the tumor suppressor gene adenomatous polyposis coli down-regulates beta-catenin but its zygotic expression is not essential for the regulation of Armadillo.
    Hayashi S; Rubinfeld B; Souza B; Polakis P; Wieschaus E; Levine AJ
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):242-7. PubMed ID: 8990193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
    Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW
    Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.